Unconventional cancer research consortium created with $3.2M grant from US Department of Defense
Funding an unconventional approach to fighting cancer that emphasizes the integration of diverse scientific disciplines, the U.S. Department of Defense has awarded $3.2 million to establish the Convergent Science Cancer Consortium (CSCC), led by Dean’s Professor of Biological Sciences Peter Kuhn at the USC Dornsife College of Letters, Arts and Sciences.
The consortium, which includes Stanford University, Cedars-Sinai Medical Center and Children’s Hospital Los Angeles as inaugural members, unites experts from fields such as biology, engineering, mathematics and computer science, to discover more effective treatment strategies through a more holistic understanding of cancer, particularly for hard-to-treat forms such as bladder cancer, sarcomas and metastatic cancers.